FCM
MDT icon

Fourpath Capital Management’s Medtronic MDT Stock Holding History

Fourpath Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.93M Buy
101,418
+9,063
+10% +$731K 1.04% 26
2026
Q1 		$8M Buy
92,355
+4,643
+5% +$445K 1.15% 20
2025
Q4 		$8.43M Buy
87,712
+69
+0.1% +$6.7K 1.15% 24
2025
Q3 		$8.35M Buy
87,643
+73
+0.1% +$6.71K 1.19% 25
2025
Q2 		$7.63M Buy
87,570
+75
+0.1% +$6.36K 1.2% 19
2025
Q1 		$7.86M Buy
87,495
+80
+0.1% +$7.16K 1.37% 19
2024
Q4 		$6.98M Sell
87,415
-46
-0.1% -$3.98K 1.29% 19
2024
Q3 		$7.87M Buy
+87,461
New +$7.36M 1.45% 15
2024
Q1 		– Sell
-6,852
Closed -$565K – 145
2023
Q4 		$565K Sell
6,852
-276
-4% -$21K 0.38% 56
2023
Q3 		$559K Buy
7,128
+786
+12% +$65.8K 0.42% 60
2023
Q2 		$559K Sell
6,342
-81
-1% -$6.97K 0.67% 46
2023
Q1 		$518K Sell
6,423
-12
-0.2% -$978 0.36% 70
2022
Q4 		$500K Buy
+6,435
New +$522K 0.36% 72
2022
Q1 		– Sell
-2,659
Closed -$275K – 169
2021
Q4 		$275K Buy
+2,659
New +$308K 0.11% 129

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fourpath Capital Management's MDT Position: Q2 2026 in Review

Fourpath Capital Management increased its Medtronic (MDT) stake by 9.8% in Q2 2026, buying an estimated $731K and bringing the position to 101,418 shares worth $7.93M. The position accounts for 1.04% of the portfolio, ranked #26.

Fourpath Capital Management first reported a position in MDT in Q4 2021 and has held it in 14 quarters since. The position peaked at $8.43M in Q4 2025. 2,133 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Fourpath Capital Management held 101,418 shares of Medtronic worth $7.93M as of Q2 2026.
  • Fourpath Capital Management bought 9,063 Medtronic shares in Q2 2026, an estimated $731K.
  • Medtronic made up 1.04% of Fourpath Capital Management's portfolio in Q2 2026, its #26 holding.
  • Fourpath Capital Management first reported a position in Medtronic in Q4 2021 and has held it in 14 quarters since.
  • Fourpath Capital Management's Medtronic position peaked at $8.43M in Q4 2025.
  • 2,133 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Fourpath Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.